Early diagnosis and modern therapies improve Crohn’s disease prognosis
Crohn’s disease, a type of inflammatory bowel disease (IBD), impacts millions worldwide. The disease is chronic and highly…
UCL launches landmark trial of Alzheimer’s blood test
A major UCL-led clinical trial, aiming to transform the diagnosis of Alzheimer’s disease through a simple blood test,…
Compact bNIRS technology could become a diagnostic toolkit for dementia
Early and accurate diagnosis of dementia remains a major challenge. Standard approaches such as MRI and PET scans…
SLIT2 protein levels in the eye and blood linked to cognitive function
Neurocognitive impairments are classified by pathological changes with potential for destruction of neural tissue. One change known to…
Fatty acids circulating in the blood predict bone mineral density from childhood to adolescence
A recent study by the University of Eastern Finland is the first to report that the fatty acid…
Amino acid homocysteine plays a key role in aortic stiffening
In addition to cholesterol, the amino acid homocysteine also plays a role in aortic stiffening. Researchers from Graz…
CPAP treatment may reduce death risk in people with both type 2 diabetes and sleep apnea
People with both type 2 diabetes (T2D) and obstructive sleep apnea have a higher risk of death, but…
Berberine improves cognitive function in diabetic encephalopathy mice
A recent study published in Engineering has shed new light on the potential therapeutic effects of berberine (BBR),…
Folic acid fortification linked to tripled gestational diabetes rates in Australian study
An Australian study suggests that mandatory folic acid fortification may have unintended consequences, linking excess folate to rising…
AI voice agents helped improve accuracy of blood pressure measurements in older adults
Artificial intelligence (AI) voice agents helped older adults with high blood pressure to accurately report their blood pressure…
Blood-based biomarkers reveal barriers to diversity in Alzheimer’s disease trials
Some of the populations with the highest risk for Alzheimer’s disease remain greatly underrepresented in clinical trials-and a…